HFMA 2017: Bryan Health’s Carol Friesen takes over as HFMA chair

The annual Healthcare Financial Management Association (HFMA) conference includes the induction of the organization’s new board chair, its chief elected officer. For 2017-18, the position belongs to Carol Friesen, MPH, vice president of health system services at Bryan Health in Lincoln, Nebraska.

Friesen brings many years of experience in leadership positions focusing on rural health, having previously served as president and CEO of Crete Area Medical Center in Crete, Neb., from 2007 to 2013 and CFO of Boone County Health Center in Albion, Neb., from 1999 to 2007. In her current role at Bryan Health, she oversees its network of critical access hospitals, physician services, medical education and workflow consulting. She’s also served as a member of the HFMA board since 2012.

“Carol is a committed, passionate leader, and we’re excited to welcome her as our new chair,” HFMA President and CEO Joseph J. Fifer said in a statement. “She brings an extensive background in healthcare finance to this new leadership position. That expertise, coupled with Carol’s experience in working with physicians, will be tremendous assets to HFMA as we continue our efforts to foster collaborative relationships among providers, physicians and health plans that will lead to high-quality, low-cost health care and healthier communities.”

Her successor will be chair-elect Kevin Brennan, executive vice president of Finance and CFO of Geisinger Health System in Danville, Penn. The 2017-18 secretary-treasurer, another position Frisen once held, will be Michael Allen, CFO of OSF Healthcare in Peoria, Illinois.

Additionally, three new board members will begin three-year terms ending in 2020: Dennis E. Dahlen, a healthcare finance executive at Banner Health in Phoenix; Marc Scher, Partner-in-Charge of KPMG LLP’s U.S. and Global Healthcare Audit Practice, based in Orange County, California; and T. Carley Williams, Partner at BKD LLP in Tulsa, Oklahoma.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup